Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-05-03FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) by Viatris Specialty LLC.
-
FDA approval · 2012-05-02FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride (Vertical Pharmaceuticals, LLC) to update the product labeling und…
-
FDA approval · 2012-04-10FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for paroxetine hydrochloride submitted by Apotex Corp.
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School Settings [Phase 2]
Phase 2 trial update noting the completion of a modular cognitive behavioral therapy program for treating child anxiety disorders in element…
-
FDA approval · 2012-01-27FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for propranolol hydrochloride from Ipca Laboratories Limited, finalizing a regulatory update for the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-12-27FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application from Mylan Pharmaceuticals for paroxetine hydrochloride hemihydrate, authorizing a generic version o…
-
FDA approval · 2011-12-15FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to manufacture and market paroxetine hydrochloride as a generic antidepressant.
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia [NA]
A completed clinical trial evaluated the effect of behavior therapy on responses to social stimuli in individuals with social anxiety disord…
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
A completed University of Michigan study investigates brain and genetic markers that predict sertraline treatment response in social anxiety…
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment [Phase 4]
Phase 4 trial evaluating quetiapine (Seroquel) for social anxiety disorder in a public speaking setting has completed.
-
FDA approval · 2011-08-19FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for SERTRALINE HYDROCHLORIDE (Mylan Pharmaceuticals Inc.), indicating regulatory action on this gene…
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder? [NA]
This clinical trial evaluated Thought Field Therapy (TFT) for anxiety disorders, including agoraphobia, social anxiety disorder, and PTSD; t…
-
FDA approval · 2011-07-27FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) from Zydus Lifesciences Limited under an ANDA.
-
CLINICAL_TRIALS research · 2011-07-08Clinical Trial Update: Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice [Phase 2, Phase 3]
This notice reports a Phase 2/Phase 3 effort to transfer manualized cognitive-behavioral therapy for social anxiety disorder into routine cl…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Escitalopram in Patients With Social Anxiety Disorder [Phase 4]
Phase 4 clinical trial evaluating escitalopram in adults with Social Anxiety Disorder; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia [Phase 2]
Phase 2 study results for intranasal PH94B in managing symptoms of Social Anxiety Disorder (generalized social phobia) have been completed, …
-
FDA approval · 2011-05-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved the original ANDA for Venlafaxine hydrochloride by Dr. Reddy's Laboratories Inc, enabling a generic version of this antidepress…
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc., authorizing a generic version of the antid…
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for venlafaxine hydrochloride, a generic antidepressant.
-
FDA approval · 2011-03-14FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling its generic product.
-
FDA approval · 2011-03-04FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited.
-
FDA approval · 2011-01-30FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Paroxetine hydrochloride by Zydus Lifesciences Limited, indicating an update to the labeling or …
-
CLINICAL_TRIALS trial_result · 2011-01-27Clinical Trial Update: Efficacy of Quetiapine in Generalised Social Anxiety Disorder [Phase 3]
A Phase 3 trial evaluating quetiapine for generalized social anxiety disorder was terminated.
-
FDA approval · 2010-12-14FDA Approved: VENLAFAXINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic venlafaxine via an Original Application (ANDA). It is indicated for major depressive disorder,…
-
FDA approval · 2010-12-10FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) submitted by NorthStar Rx LLC. This action represents an a…